IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PIZZI, Marina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.151
EU - Europa 7.312
AS - Asia 5.439
SA - Sud America 973
AF - Africa 102
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 17
AN - Antartide 1
Totale 24.013
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.988
PL - Polonia 3.260
CN - Cina 1.849
SG - Singapore 1.658
UA - Ucraina 1.049
BR - Brasile 822
DE - Germania 750
IT - Italia 725
HK - Hong Kong 601
VN - Vietnam 448
GB - Regno Unito 350
FI - Finlandia 324
IN - India 299
RU - Federazione Russa 237
TR - Turchia 202
IE - Irlanda 178
FR - Francia 174
CA - Canada 86
BD - Bangladesh 76
ID - Indonesia 64
MX - Messico 50
AR - Argentina 49
NL - Olanda 47
SE - Svezia 45
BE - Belgio 41
JP - Giappone 38
ZA - Sudafrica 38
KR - Corea 33
CZ - Repubblica Ceca 31
ES - Italia 30
IQ - Iraq 30
AT - Austria 25
EC - Ecuador 23
PK - Pakistan 22
CO - Colombia 21
UZ - Uzbekistan 19
IR - Iran 17
MA - Marocco 17
EU - Europa 16
IL - Israele 16
AU - Australia 15
KE - Kenya 15
CL - Cile 13
VE - Venezuela 13
PY - Paraguay 11
AE - Emirati Arabi Uniti 9
JO - Giordania 9
PE - Perù 9
SA - Arabia Saudita 9
AZ - Azerbaigian 8
LT - Lituania 8
UY - Uruguay 8
OM - Oman 7
EG - Egitto 6
ET - Etiopia 6
JM - Giamaica 6
MU - Mauritius 6
TN - Tunisia 6
CH - Svizzera 5
LV - Lettonia 5
BO - Bolivia 4
HN - Honduras 4
KZ - Kazakistan 4
RO - Romania 4
BG - Bulgaria 3
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
EE - Estonia 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
AL - Albania 2
AM - Armenia 2
DZ - Algeria 2
GE - Georgia 2
GR - Grecia 2
MD - Moldavia 2
NP - Nepal 2
PA - Panama 2
PH - Filippine 2
PS - Palestinian Territory 2
PT - Portogallo 2
SN - Senegal 2
SV - El Salvador 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
GA - Gabon 1
GD - Grenada 1
GS - Georgia del Sud e Isole Sandwich Australi 1
GT - Guatemala 1
HR - Croazia 1
KY - Cayman, isole 1
LB - Libano 1
Totale 24.001
Salva come PNG Salva come JPEG
Città #
Warsaw 3.255
Fairfield 1.040
Ashburn 845
Woodbridge 812
Jacksonville 732
Singapore 731
Houston 619
Hong Kong 595
Ann Arbor 491
Chandler 474
Cambridge 441
Beijing 415
Seattle 410
Wilmington 386
Princeton 315
Nanjing 298
Brescia 281
New York 260
Los Angeles 218
Dearborn 206
Dublin 177
Dallas 167
Helsinki 164
Istanbul 163
The Dalles 145
Dong Ket 126
Munich 111
Des Moines 100
Ho Chi Minh City 100
Buffalo 98
Nanchang 90
Chicago 85
Pune 83
Shenyang 79
Milan 77
São Paulo 77
San Francisco 76
Moscow 73
Hanoi 72
Hebei 71
Jinan 69
Redondo Beach 68
Tianjin 68
Lancaster 65
Shanghai 65
Changsha 60
San Diego 52
Jakarta 48
London 48
Santa Clara 45
Brussels 38
Phoenix 38
Council Bluffs 35
Turku 35
Denver 33
Brooklyn 32
Kunming 32
Toronto 32
Jiaxing 30
Orem 29
Guangzhou 28
Ningbo 28
Zhengzhou 28
Salt Lake City 27
Hangzhou 25
Montreal 24
Nuremberg 24
Chennai 23
Rio de Janeiro 23
Lanzhou 22
Taizhou 22
Tokyo 22
Verona 21
Brasília 20
Norwalk 20
Boardman 19
Brno 19
Johannesburg 19
Stockholm 19
Tashkent 19
Amsterdam 18
Atlanta 18
Boston 18
Orange 18
Poplar 18
Rome 18
Tampa 18
Belo Horizonte 17
Haikou 17
Mexico City 17
Porto Alegre 17
Augusta 16
San Mateo 16
Baghdad 15
Manchester 15
Dhaka 14
Mumbai 14
Nairobi 14
Romola 14
Thái Bình 14
Totale 16.658
Salva come PNG Salva come JPEG
Nome #
CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloid 358
Neuroprotective and Anti-Apoptotic Effects of CSP-1103 in Primary Cortical Neurons Exposed to Oxygen and Glucose Deprivation 338
PEA and luteolin synergistically reduce mast cell-mediated toxicity and elicit neuroprotection in cell-based models of brain ischemia 312
Glutamatergic neurons induce expression of functional glutamatergic synapses in primary myotubes. 311
Glutamatergic Reinnervation and Assembly of Glutamatergic Synapses in Adult Rat Skeletal Muscle Occurs at Cholinergic Endplates 303
1B/(-)IRE DMT1 Expression during Brain Ischemia Contributes to Cell Death Mediated by NF-κB/RelA Acetylation at Lys310 296
Dopamine transporter/α-synuclein complexes are altered in the post mortem caudate putamen of Parkinson’s disease: An in situ proximity ligation assay study 289
Glutamatergic reinnervation through peripheral nerve graft dictates assembly of glutamatergic synapses at rat skeletal muscle 283
Priming of cultured neurons with sabeluzole results in long-lasting inhibition of neurotoxin-induced tau expression and cell death. 277
NF-κB and epigenetic mechanisms as integrative regulators of brain resilience to anoxic stress. 276
Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window. 272
NF-κB in Innate Neuroprotection and Age-Related Neurodegenerative Diseases 270
Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease 267
Acetylation state of RelA modulated by epigenetic drugs prolongs survival and induces a neuroprotective effect on ALS murine model 264
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice. 256
The End Is the Beginning: Parkinson's Disease in the Light of Brain Imaging 256
A Polyphenol-Enriched Supplement Exerts Potent Epigenetic-Protective Activity in a Cell-Based Model of Brain Ischemia 256
Mild inflammatory profile without gliosis in the c-rel deficient mouse modeling a late-onset parkinsonism 255
Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation 254
The Contribution of -Synuclein Spreading to Parkinson’s Disease Synaptopathy 249
Synergistic association of valproate and resveratrol reduces brain injury in ischemic stroke 245
Pharmacological targeting of the beta-amyloid precursor protein intracellular domain 219
1,2,4-Triazine derivatives as agents for the prevention of AGE-RAGE-mediated inflammatory cascade in THP-1 monocytes: An approach to prevent inflammation-induced late diabetic complications 217
Mitochondria and alpha-synuclein: Friends or foes in the pathogenesis of Parkinson's disease? 200
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 193
Chapter 24 NF-KappaB Dimers in the Regulation of Neuronal Survival 189
Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate 189
NUOVO IMPIEGO TERAPEUTICO PREVENTIVO DELLA SUBUNITA' C-REL DELLA PROTEINA NF-KAPPAB E NUOVO IMPIEGO DI UN ANIMALE TRASGENICO NON UMANO CHE PORTA LA DELEZIONE DEL GENE C-REL (C-REL-/-) 188
The gamma-Secretase Modulator CHF5074 Reduces the Accumulation of Native Hyperphosphorylated Tau in a Transgenic Mouse Model of Alzheimer's Disease 187
Targeting IKK2 by pharmacological inhibitor AS602868 prevents excitotoxic injury to neurons and oligodendrocytes. 186
c-Rel deficient mice, a mouse model of "spreading" PD-like pathology. 186
NF-κB/c-Rel deficiency causes Parkinson's disease-like prodromal symptoms and progressive pathology in mice 186
The Role of Mast Cells in Stroke 186
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 184
Spinal cord mGlu1a receptors - Possible target for amyotrophic lateral sclerosis therapy 181
Post-ischemic brain damage: NF-kappaB dimer heterogeneity as a molecular determinant of neuron vulnerability 177
NF-kappaB p50/RelA and c-Rel-containing dimers: opposite regulators of neuron vulnerability to ischaemia. 176
Bim and Noxa are candidates to mediate the deleterious effect of the NF-kappa B subunit RelA in cerebral ischemia. 173
Activation of dopamine D2 receptors linked to voltage-sensitive potassium channels reduces forskolin-induced cyclic AMP formation in rat pituitary cells. 173
A mechanism additional to cyclic AMP accumulation for vasoactive intestinal peptide-induced prolactin release. 171
A Tau antisense oligonucleotide decreases neurone sensitivity to excitotoxic injury. 170
Activation of multiple metabotropic glutamate receptor subtypes prevents NMDA-induced excitotoxicity in rat hippocampal slices. 163
Expression of functional NR1/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line 162
α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons 162
EXACERBATED AGE-DEPENDENT LOSS OF NIGRAL DOPAMINERGIC NEURONS IN NF-KAPPAB C-REL -/- MICE 156
Cellular mechanisms for neurotensin receptor-mediated release of prolactin. 152
Activation of NF-kappaB p65/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP(+) toxicity in SK-N-SH cells. 152
c-Rel deficient mice, a mouse model of “spreading” PD-like pathology 152
The gamma-secretase modulator CHF5074 elicits neuroprotection and increases histone acetylation in primary cortical neurons exposed to oxygen glucose deprivation 151
Antisense strategy unravels tau proteins as molecular risk factors for glutamate-induced neurodegeneration. 150
Electrophysiological and metabolic effects of CHF5074 in the hippocampus: protection against in vitro ischemia. 150
Synapsin III alterations in Parkinson's disease 149
N-methyl-D-aspartate neurotoxicity in hippocampal slices: protection by aniracetam. 149
Mitochondrial Dysfunction and Alpha-Synuclein Synaptic Pathology in Parkinson’s Disease: Who’s on First? 148
Cortical neurons induce the expression of glutamate receptors in primary myotubes 145
Degenerazione età –dipendente dei neuroni dopaminergici della sostanza nera nei topi NF-kappaB cRel 145
Synergistic association of valproate and resveratrol reduces brain injury in ischemic stroke. 145
A bioinformatics analysis of memory consolidation reveals involvement of the transcription factor c-rel. 143
SYNERGIC ROLE OF RESVERATROL AND HDACi MS-275 IN NEUROPROTECTION 143
Acetylation of NF-kappaB p50/RelA and histones in the epigenetic regulation of pro-apoptotic transcription: a neuroprotective target in brain ischemia 140
Inhibition of glutamate-induced neurotoxicity by a tau antisense oligonucleotide in primary culture of rat cerebellar granule cells 139
Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells. 137
Soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro differentiation of purified rat oligodendroglial lineage cells. 136
Pharmacological basis for dopamine D-2 receptor diversity 136
Involvement of Synapsin III in the onset of alpha-synuclein synaptic pathology in Parkinson’s disease 136
Dopamine D2 receptor stimulation inhibits inositol phosphate generating system in rat striatal slices. 135
Risk and protective factors associated with mental health status in an Italian sample of students during the fourth wave of COVID-19 pandemic 134
Differential pattern of expression of G proteins in nucleus striatum from 6-hydroxydopamine lesioned rats. 134
Differential expression of fetal and mature tau isoforms in primary cultures of rat cerebellar granule cells during differentiation in vitro 134
Repeated administration of (−) sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions 133
Tolerance to hypoactivity and sensitization to hyperactivity after chronic treatment with a presynaptic dose of lisuride in rats 132
Inhibition of IκBα phosphorylation prevents glutamate-induced NF-κB activation and neuronal cell death 132
Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol. 130
An in vitro method of diagnosing Parkinson's disease 130
Opposing regulation of amyloid precursor protein by ionotropic and metabotropic glutamate receptors. 129
Various Ca2+ entry blockers prevent glutamate-induced neurotoxicity. 128
Lack of vasoactive intestinal peptide-releasing property in prolactin cells from ovariectomized rats: contribution of post-transductional impairments 127
The differential coupling mechanism of dopamine D-2 receptor subtypes: importance for the actions of neuroleptic drugs 126
Spinal cord mGlu1a receptors: possible target for amyotrophic lateral sclerosis therapy. 126
Synapsin III Alteration in Parkinson's disease 126
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease 126
A soluble interleukin-6 (IL6) recepetor/IL6 fusion protein enhances the in vitro differentiation of purified rat oligodendroglial lineage cells 125
Peripheral and central mechanisms of action of serotoninergic anorectic drugs. 123
Involvement of Synapsin III in the onset of Alpha-synuclein pathology in Parkinson’s Disease 123
AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons of Synapsin III knockout mice reveals novel molecular features involved in Parkinson's disease pathology. 122
Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices 121
Synapsin III Alteration in Parkinson's disease 121
Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation 120
Properties of benzodiazepine binding sites in peripheral blood lymphocytes 120
Post-synaptic D1 and D2 dopamine receptors are present in rabbit renal and mesenteric arteries 119
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of Parkinson’s disease and dementia with Lewy bodies, 119
NF-kappaB pathway: a target for preventing beta-amyloid (Abeta)-induced neuronal damage and Abeta42 production 118
Leptin increases axonal growth cone size in developing mouse cortical neurons by convergent signals inactivating glycogen synthase kinase-3beta. 117
CHF5074, a novel gamma-secretase modulator, attenuates brain beta-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease. 117
Differential up-regulation of D-1 and D-2 dopamine receptor function in mesostriatal areas but not in cortical-limbic brain regions of rats chronically treated with (?)sulpiride and SCH 23390 117
DIVALENT METAL TRANSPORTER 1-DEPENDENT ISCHEMIC NEURODEGENERATION: STRATEGIES TO KNOCKDOWN FERROUS IRON UPTAKE 117
The inhibitor of IkappaBalpha phosphorylation BAY 11-7082 prevents NMDA neurotoxicity in mouse hippocampal slices. 116
The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injury. 116
Group-I metabotropic glutamate receptors: hypotheses to explain their dual role in neurotoxicity and neuroprotection. 115
Blockade of the tumor necrosis factor-related apoptosis inducing ligand death receptor DR5 prevents beta-amyloid neurotoxicity. 115
Totale 17.502
Salva come PNG Salva come JPEG
Categoria #
all - tutte 104.339
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.339
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.955 0 0 0 0 0 293 190 336 404 267 279 186
2021/20221.396 121 272 25 37 25 64 87 77 70 181 129 308
2022/20231.311 187 34 56 102 134 329 3 132 192 27 58 57
2023/20241.384 92 34 120 82 68 325 55 66 276 31 33 202
2024/20253.480 24 44 34 408 344 208 335 122 513 164 864 420
2025/20264.444 707 896 551 1.048 745 497 0 0 0 0 0 0
Totale 24.586